Storage conditions and storage precautions for giritinib (segatan)

Gilitinib is an oral small molecule inhibitor of FLT3, mainly used to treat patients with relapsed or refractory acute myeloid leukemia (AML) who carry FLT3 mutations. By selectively inhibiting FLT3 kinase activity and blocking abnormal signaling pathways, giritinib can inhibit leukemia cell proliferation and promote apoptosis. As an oral targeted drug, its drug stability and storage conditions directly affect its efficacy and safety.

Giritinib should be stored in a dry, cool, and dark environment. The usual recommended storage temperature is 20°C to 25°C (room temperature), allowed in the short term Stored within the range of 15°C to 30°C. Avoid high temperature, humidity and direct sunlight to prevent the decomposition or degradation of active pharmaceutical ingredients and ensure stable efficacy.

Giritinib should be kept in its original packaging and protected from direct contact with air and moisture. The bottle cap should be closed tightly and try to use it within the specified time after opening. If it is tablets, avoid mixing them with other drugs to prevent misuse or cross-contamination. Home storage should be kept away from children and pets to avoid accidental ingestion or poisoning.

During daily use, the medicine should be taken strictly according to the doctor's prescription. Do not adjust the dosage or take it in slices by yourself. When transporting or taking it out, you should use a sealed medicine box or moisture-proof bag to avoid high temperature or exposure to the sun. If the tablets have a color change, an odor or are damaged, stop using them and consult a pharmacist or doctor. Proper storage of giritinib not only ensures efficacy, but also maximizes drug safety.

Reference materials:https://www.drugs.com/